Company Information

TTK HEALTHCARE LTD.

NSE : TTKHLTCAREBSE : 507747ISIN CODE : INE910C01018Industry : Pharmaceuticals & DrugsHouse : TTK
BSE1504.55-20.45 (-1.34 %)
PREV CLOSE ( ) 1525.00
OPEN PRICE ( ) 1531.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 208
TODAY'S LOW / HIGH ( )1504.55 1545.70
52 WK LOW / HIGH ( )1117.05 1725.85
NSE1512.70-15.55 (-1.02 %)
PREV CLOSE( ) 1528.25
OPEN PRICE ( ) 1535.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4417
TODAY'S LOW / HIGH( ) 1507.15 1551.30
52 WK LOW / HIGH ( )1101.2 1744
ChairmanT T Raghunathan
Company SecretaryS Kalyanaraman
Promoter & Non-Executive DirectorT T Mukund
Independent Non-Executive DirectorVandana R Walvekar
Girish Rao
S Balasubramanian
N Ramesh Rajan
V Ranganathan
Non Independent & Non Executive DirectorR K Tulshan
K Shankaran
Incorporation Year : 1958

Registered Office :

Address : No 6 , Cathedral Road, , Chennai,
Tamil Nadu-600086 .

Phone : 044-28116106-08

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE,MCX

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.